a deep understanding of novel
science while creating value
breakthrough science addressing
high unmet medical need
financing rounds across Seed,
Early-Stage, XO, PIPE and IPO
Dewpoint Therapeutics Announces Completion of $150 Million Series C Financing
Dewpoint Therapeutics Announces Completion of $150 Million Series C Financing (prnewswire.com)
22.02.04Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medi
Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically Defined Diseases | Business | thefacts.com
22.01.11Shoreline Biosciences Announces $140M Financing To Advance Pipeline Of Next Generation Cell Immunoth
Shoreline Biosciences Announces $140M Financing To Advance Pipeline Of Next Generation Cell Immunotherapies (prnewswire.com)
21.11.03ReCode Scores $80 Million to Advance mRNA-Based Cystic Fibrosis, PCD Programs
ReCode Scores $80 Million to Advance mRNA-Based Cystic Fibrosis, PCD Programs | BioSpace
21.10.25Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases (prnewswire.com)
21.10.25Sonoma Biotherapeutics Raises $265 Million in an Oversubscribed Series B Financing to Translate the
Sonoma Biotherapeutics Raises $265 Million in an Oversubscribed Series B Financing to Translate the Promise of Cell Therapy into Curative Medicines for Autoimmune and Other Inflammatory Diseases | Business Wire
21.08.06Elevation Oncology Announces Pricing of Initial Public Offering
Elevation Oncology Announces Pricing of Initial Public Offering (prnewswire.com)
21.07.01Accent Therapeutics Announces $63 Million Series B Financing to Advance Novel, Precision Cancer Ther
Accent Therapeutics Announces $63 Million Series B Financing to Advance Novel, Precision Cancer Therapies Targeting RNA-Modifying Proteins | Business Wire
21.04.13Silverback Therapeutics Raises $78.5 Million in Oversubscribed Series B Financing
Silverback Therapeutics Raises $78.5 Million in Oversubscribed Series B Financing | Business Wire
21.04.13Akrevia Therapeutics Rebrands as Xilio Therapeutics and Announces $100.5 Million Series B Financing
Akrevia Therapeutics Rebrands as Xilio Therapeutics and Announces $100.5 Million Series B Financing | Business Wire
21.04.13Harpoon Therapeutics Announces Closing of $70M Series C Financing
Harpoon Therapeutics Announces Closing of $70M Series C Financing | Business Wire
21.04.13NextCure Raises $93 Million in Series B Financing
NextCure Raises $93 Million in Series B Financing | Business Wire
21.04.13Surrozen Secures $50M in Series B Financing
Surrozen Secures $50M in Series B Financing | FinSMEs
21.04.13에이치엘비 RCPS, 운용사 한번 더 '러브콜'
더벨 - 국내 최고 자본시장(Capital Markets) 미디어 (thebell.co.kr)
21.04.13Morphic Therapeutic Raises $80M in Series B Financing
Morphic Therapeutic Raises $80M in Series B Financing | FinSMEs
21.04.13Fulcrum Therapeutics Announces $80 Million Series B Financing
Fulcrum Therapeutics Announces $80 Million Series B Financing | Business Wire
21.04.13Constellation Pharmaceuticals Raises $100M Financing
Constellation Pharmaceuticals Raises $100M Financing | FinSMEs
21.04.13ORIC Pharmaceuticals Raises $50M Series C Financing
ORIC Pharmaceuticals Raises $50M Series C Financing | FinSMEs
21.04.13상장 앞둔 아이큐어, 150억 투자 유치
더벨 - 국내 최고 자본시장(Capital Markets) 미디어 (thebell.co.kr)
21.04.13Immatics Closes $58m Series E Financing Round
Immatics Closes $58m Series E Financing Round | FinSMEs
21.04.13에이비엘바이오, 200억원 투자유치.."이중항체 올해 1상 돌입"
에이비엘바이오, 200억원 투자유치.."이중항체 올해 1상 돌입" - 바이오스펙테이터 (biospectator.com)
21.04.13Antiva Biosciences Closes $22M Series C Financing
Antiva Biosciences Closes $22M Series C Financing | FinSMEs
21.04.13지놈앤컴퍼니, 40억 규모 후속 투자 유치
더벨 - 국내 최고 자본시장(Capital Markets) 미디어 (thebell.co.kr)
21.04.13Gobiquity Secures $6M in Series B Funding and Achieves Over 100,000 Children Screened
Gobiquity Secures $6M in Series B Funding and Achieves Over 100,000 Children Screened | Business Wire
21.04.13